Navigation Links
Important Information Regarding the Genetics of Alzheimer’s Disease and Dementia Announced by One Million Solutions in Health™
Date:1/31/2017

One Million Solutions in Health is proud to announce and share this webinar, “Genetics of Alzheimer's Disease and Dementia” by Dr. Arnold I. Pallay, FAAFP, Associate Director Jacobs Levy Personalized Genomic Medicine Program Atlantic Health System, Associate Clinical Professor Department of Family Medicine Rutgers Robert Wood Johnson Medical School and New Jersey Medical School Graduate School of Medicine, Seton Hall University.

As the population ages, increasing cases of dementia, especially Alzheimer’s type are uncovered and diagnosed. The genetics of these conditions are rapidly being elucidated and have been of interest to the scientific community and the lay public alike.

Genetic tests can suggest a higher degree of likelihood for patients to develop such conditions which, contrary to popular thought, is of value to patients in their normal routine of health care and preventative medicine.

This webinar focuses on the complex genetics that seem to make us prone to such conditions as we age. Review the webinar here: Genetics of Alzheimer's Disease and Dementia.

ABOUT ONE MILLION SOLUTIONS IN HEALTH:

As a not-for-profit, the goal of One Million Solutions in Health™ is to shape health care by sharing solutions and, importantly, to accelerate the discovery, development and delivery ... of innovative cures, treatments and preventative measures for patients around the world. By facilitating efforts to ensure organizations can Connect, Learn + Share, Innovate and Collaborate, our vision is to improve health care delivery, accelerate life sciences research and share patient and consumer-focused ideas and solutions.

By engaging scientists, entrepreneurs, investors, innovators, industry experts, health care professionals, and patients across various disciplines, and from around the world, we can utilize the power of the internet to disrupt things in a positive and transformative way to accelerate the movement of new solutions and scientific discoveries from the scientist to the patient.

The Technology Evaluation Consortium (TEC) brings together life sciences and/or health care companies and technology providers, and other relevant partners (e.g., government and Universities) to evaluate and validate technologies or services in a collaborative environment. The model empowers technology providers and industry end users to collectively assess a number of technologies in a cost-effective manner, producing a depth and breadth of results that no company can achieve alone.

We are on our way towards accelerating high-potential innovations, catalyzing investment and increasing awareness of, and support for, important ideas to improve health and save lives. We are thrilled to have you be a part of this transformative journey!

IF YOU HAVE A TECHNOLOGY, SCIENTIFIC DISCOVERY OR MEDICAL SOLUTION YOU WOULD LIKE US TO HELP SHARE WITH THE WORLD, CONTACT US.

For more information: http://www.onemillionsolutionsinhealth.org

CONTACT:

One Million Solutions in Health™
Dawn Van Dam
Executive Director & CEO
Email: dawn.vandam(at)onemillionsolutionsinhealth(dot)org
Phone: 416-402-8274
Twitter: @DawnVanDam

Read the full story at http://www.prweb.com/releases/2017/02/prweb14028811.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
2. How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today
3. Important breakthrough in identifying effect of epilepsy treatment
4. York researchers discover important mechanism behind nanoparticle reactivity
5. Respiratory Update: Interpreting Minimal Clinically Important Differences in COPD and Demonstrating Product Value with PROs, a New Life Science webinar Hosted by Xtalks
6. September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month!
7. Green Dot To Sponsor “Zero Waste” Fashion Show at the Plastics Industry’s Most Important Trade Event
8. Australian Studies Confirm Anisina as Potential Important New Weapon Against Melanoma
9. BioAmber Achieves Important Milestone: Sarnia Construction Substantially Complete
10. DOE (Department of Energy) Reports that Direct AC LED Technology and High-Voltage LEDs are Important for the Future of SSL
11. RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2018)... LINDA, Calif. (PRWEB) , ... December 18, 2018 , ... ... after a lumpectomy have better quality of life post-treatment versus whole breast irradiation, a ... two — are typically treated with whole breast irradiation after removal of the cancerous ...
(Date:12/13/2018)... ... December 12, 2018 , ... RURO, ... solutions, announces the Limfinity® ML (Machine Learning) addition for its Limfinity® 7 framework. ... within Limfinity® solutions. In the module, trained models make predictions based on user ...
(Date:12/10/2018)... , ... December 10, 2018 ... ... integrated Contract Development and Manufacturing Organization (CDMO) with sites in China and ... cGMP manufacturing, and aseptic fill finish solutions for monoclonal antibody (mAb) and ...
(Date:12/5/2018)... ... December 05, 2018 , ... STRmix™ – sophisticated forensic software capable of ... been used to convict a Wyoming man of third-degree sexual assault, a felony punishable ... to test for DNA on the couch cushions on which the sexual assault was ...
Breaking Biology Technology:
(Date:12/27/2018)... (PRWEB) , ... December 27, 2018 , ... ... Microbiome Conference at JPM as part of the JP Morgan 37th Annual Healthcare ... scientists and physicians, and members of the investment community. , Since its ...
(Date:12/19/2018)... ... ... NDA Partners Chairman Carl Peck, MD, announced today that Deb Koeneman, ... and Radiological Health (CDRH), has been appointed a Partner in the firm. Ms. Koeneman ... more than 25 years of regulatory experience. In addition to her FDA career, she ...
(Date:12/18/2018)... ... 18, 2018 , ... Nativis, Inc. , a clinical ... today announced the publication of an early feasibility study in CNS Oncology suggesting ... The publication of the study, An Early Feasibility Study of the Nativis Voyager® ...
Breaking Biology News(10 mins):